Polar Capital Holdings PLC Blueprint Medicines Corp Transaction History
Polar Capital Holdings PLC
- $14.9 Billion
- Q1 2025
A detailed history of Polar Capital Holdings PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Polar Capital Holdings PLC holds 541,379 shares of BPMC stock, worth $54.2 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
541,379
Previous 626,379
13.57%
Holding current value
$54.2 Million
Previous $54.6 Million
12.29%
% of portfolio
0.32%
Previous 0.34%
Shares
10 transactions
Others Institutions Holding BPMC
# of Institutions
390Shares Held
68.6MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$665 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$664 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$542 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$385 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$308 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...